Companies attending
Companies attending
Emerging companies across the resources, life sciences and technology sectors will be attending and hosting meetings at the Ignite Investment Summit Hong Kong on 14 – 15 October 2026.
If you’re a qualified investor who would like to arrange 1-on-1 meetings with any of these companies, click here for investor registration and access to our Meeting Planner which contains profiles of each participating company, their projects, and management teams.
Emerging companies across the resources, life sciences and technology sectors will be attending and hosting meetings at the Ignite Investment Summit Hong Kong on 14 – 15 October 2026.
If you’re a qualified investor who would like to arrange 1-on-1 meetings with any of these companies, click here for investor registration and access to our Meeting Planner which contains profiles of each participating company, their projects, and management teams.
Resources companies
| Company Name | Exchange | Ticker | Stage | Commodity | Project Location | Market Cap |
|---|---|---|---|---|---|---|
| ACG Metals | LON | ACG | Development | Copper | Balikser, Turkey | £381.32M 🇬🇧 |
| ATHA Energy | TSXV | SASK | Exploration | Uranium | Nanavut, Canada | $409.76M 🇨🇦 |
| Aventine Resources | Private | Private | Exploration | Gold, Copper | Western Australia | Pre-IPO |
| Blackrock Silver | TSXV, OTCQX | BRC, BKRRF | Development | Gold, Silver | Nevada, United States | $478.93M 🇨🇦 |
| Challenger Gold | ASX | CEL | Exploration | Gold, Copper | Argentina, Ecuador | $380.74M 🇦🇺 |
| Cobre | ASX | CBE | Exploration, Production | Copper | Chile, South America | $318.50M 🇦🇺 |
| Critica | ASX | CRI | Exploration | Rare Earth Elements (REE) | Western Australia | $76.68M 🇦🇺 |
| Ecora Royalties | LSE, TSX, OTCQX | ECOR, ECOR, ECRAF | N/A | Cobalt, Copper, Nickel, Rare Earths, Uranium | N/A | £339.71M 🇬🇧 |
| Empire Metals | LON | EEE | Development | Titanium | Western Australia | £275.78M 🇬🇧 |
| Estrella Resources | ASX | ESR | Exploration | Manganese | Timor-Leste, Western Australia | $61.90M 🇦🇺 |
| First Graphene | ASX | FGR | Development | Graphene | Western Australia | $46.03M 🇦🇺 |
| Godolphin Resources | ASX | GRL | Exploration, Development | Critical Minerals, Gold, Copper, Rare Earths Elements (REE) | New South Wales, Australia | $14.49M 🇦🇺 |
| Horizon Gold | ASX | HRN | Exploration, Development | Gold | Western Australia | $210.38M 🇦🇺 |
| Iron Bear Resources | ASX | IBR | Development | Iron Ore | Canada | $64.11M 🇦🇺 |
| Jade Gas | ASX | JGH | Exploration | Gas | Mongolia | $168.71M 🇦🇺 |
| Kalgoorlie Gold Mining | ASX | KAL | Exploration | Gold | Western Australia | $13.22M 🇦🇺 |
| Kaoko Metals | ASX | KAO | Exploration | Copper, Silver | Namibia, South Africa | $17.18M 🇦🇺 |
| Kingfisher Metals | TSXV, OTCQX | KFR | Exploration | Copper, Gold | Canada | $131.41M 🇨🇦 |
| Latitude 66 | ASX | LAT | Exploration, Development | Critical Minerals, Gold | Finland, Europe, Western Australia | $18.69M 🇦🇺 |
| LinQ Minerals | ASX | LNQ | Exploration | Copper, Gold | New South Wales, Australia | $32.78M 🇦🇺 |
| Maronan Metals | ASX, OTCQB | MMA | Exploration | Copper, Gold, Lead, Silver | Australia | $144.56M 🇦🇺 |
| Metals One | LON | MET1 | Exploration, Development | Copper, Gold, Graphite, Helium, Lithium, Nickel, PGEs, Uranium | Africa, Europe, North America, South America | £16.49 🇬🇧 |
| MetalsGrove | ASX | MGA | Exploration | Gold | West Africa | $15.90M 🇦🇺 |
| Miata Metals | TSXV | MMET | Exploration | Gold | Suriname | $51.81M 🇨🇦 |
| MinRex Resources | ASX | MRR | Exploration, Development | Copper, Gold, Silver | Serbia | $27.37M 🇦🇺 |
| Nordic Resources | ASX | NNL | Exploration, Development | Gold | Finland, Europe | $77.29M 🇦🇺 |
| Ore Resources | ASX | OR3 | Exploration | Gold, Lithium | Western Australia | $66.96M 🇦🇺 |
| Oroco Resources | TSXV | OCO | Exploration | Copper, Gold | Mexico, South America | $140.10M 🇨🇦 |
| Pilbara Gold | ASX | PGL | Exploration | Gold | Western Australia | $130.88M 🇦🇺 |
| Pinnacle Silver and Gold | TSX, OTCQB, Frankfurt | PINN, PSGCF, P9J | Exploration, Development | Gold, Silver | Mexico, South America, Canada | $15.20M 🇨🇦 |
| Pure One | ASX | P1E | Production | Hydrogen | New South Wales, Australia | $24.06M 🇦🇺 |
| Pursuit Minerals | ASX | PUR | Exploration | Lithium | Argentina | $15.81M 🇦🇺 |
| Q2 Metals | TSXV, OTCQB | QTWO, QUEXF | Exploration, Development | Lithium | Canada | $617.57M 🇨🇦 |
| Red Metal | CSE | RDM | Exploration | Cobalt, Copper, Gold, Silver | Chile | $5.39M 🇨🇦 |
| Red Mountain Mining | ASX | RMX | Exploration | Antimony | Western Australia | $13.36M 🇦🇺 |
| Sky Metals | ASX | SKY | Exploration, Development | Tin | Australia | $251.63M 🇦🇺 |
| Stellar Resources | ASX | SRZ | Exploration | Tin | Australia | $106.83M 🇦🇺 |
| Sunstone Metals | ASX | STM | Exploration | Copper, Gold, Silver | Ecuador | $63.58M 🇦🇺 |
| Vertex Minerals | ASX | VTX | Exploration, Development, Production | Gold | Australia | $32.96M 🇦🇺 |
| White Cliff Minerals | ASX, OTCQB | WCN, WCMLF | Exploration | Copper | Canada | $44.75M 🇦🇺 |
Life sciences companies
| Company Name | Exchange | Ticker | Sub Sector | Stage | Services / Products | Market Cap |
|---|---|---|---|---|---|---|
| Dimerix | ASX | DXB | Biopharmaceutical | Clinical Stage | Develops drug candidates for inflammatory diseases, including kidney and respiratory conditions. | $99.07M 🇦🇺 |
| Emyria | ASX | EMD | Biotech | Clinical Stage | Clinical services and drug development company specialising in neuroscience and mental health | $29.53M 🇦🇺 |
| Firebrick Pharma | ASX | FRE | Biotech | Commercialisation | Nasodine® Nasal Spray (0.5% PVP-I): The company’s flagship product designed to target and eliminate germs (viruses and bacteria) causing respiratory infections. | $12.57M 🇦🇺 |
| Paradigm Biopharma | ASX | PAR | Biopharmaceutical | Late-stage drug development | Develops injectable pentosan polysulfate sodium (iPPS) for osteoarthritis treatment. | $89.36M 🇦🇺 |
| Recce Pharmaceuticals | ASX | RCE | Biotech | Commercialisation | Developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health threat of antibiotic-resistant superbugs. | $157.60M 🇦🇺 |